Precision AQ

We're excited to announce that the Precision AQ blog is now live! Our team of experts will be sharing insights and thought leadership on key topics shaping the healthcare industry. Here's what we've been writing about recently: - Reimbursement Challenges in Oncology - The Upside-Downs of Medical Benefit Drug Reimbursement - How Competitive Cx Benchmarking Could Lead to Improved Business Outcomes - Sickle Cell Disease & Gene Therapy Model Explore these articles and more for expert insights and fresh perspectives: https://lnkd.in/ejnFDnNQ

Our teams are busy finishing the work of 2024, so we delegated the making of our seasonal message to the kids of Precision. Check out a little perspective on a big year!

Our CEO, Margaret Keegan, is featured in the December issue of Pharmaceutical Executive candidly discussing the future of clinical development, the changing commercialization sector and the manufacturing of tomorrow’s medicines. The article also highlights what is possible now with AI and how Precision is helping navigate biotechnology and pharmaceutical companies into the next era of healthcare: https://lnkd.in/eSF4Dx5C #clinical #manufacturing #research #biotechnology #pharmaceutical #drugspharmaceuticals #health #healthcare #womeninscience #science

Did you know Japan accounts for 6% of global pharma sales and sets the pricing benchmark for Asia-Pacific? Succeeding in this market takes more than pricing—it’s about strategy, innovation, and mastering the cost-effectiveness evaluation (#CEE) process. Ross Maclean shares 6 expert tips to help navigate this unique market and unlock its full potential in PMLive. Don’t miss out on this roadmap to opportunity: https://lnkd.in/eGgMbKxp #GlobalHealthcare #MarketAccess #AsiaPacificMarkets #PharmaInnovation

From January 13-16, Precision's Investor Relations & External Communications team will be in San Francisco, ready to engage with industry leaders, investors and innovators in the healthcare space. With deep expertise in biotech across all stages of development, we craft strategies that connect biotech innovators with the financial community. We're here to help tell your story, amplify your impact and foster credibility at every key milestone. If you're in San Francisco this January, we'd love to connect! Shoot us a meeting request here: https://lnkd.in/ewPKpaYw

Cell & gene therapies hold incredible potential—but can they truly transform healthcare if patients can’t access them? Centralized manufacturing is falling short, but decentralized manufacturing offers a bold solution—bringing production closer to patients, cutting vein-to-vein times, and improving outcomes. Our experts, Erin Lopata, Philip Cyr, and Molly Borchardt, share insights in CGTLive on how this innovative approach is reshaping patient care and the C&GT industry. #CellAndGeneTherapy #PatientCare #FutureOfHealthcare

Our HEOR team is breaking new ground in evidence synthesis! We’re proud to announce our collaboration with BMS (Sven Klijn, Devender Dhanda RPh MS MBA PhD, and Bill Malcolm), published in Value in Health: Developing Multi-Level Network Meta-Regression (ML-NMR) for time-to-event outcomes. A big shoutout to Dylan Maciel, Jeroen Paul Jansen, Kevin Towle, and Shannon Cope for leading the charge. Your work is continuously shaping the field of evidence synthesis for health technology assessment. Explore the full details of our latest publication: https://lnkd.in/eHjEMRj5 #HEOR #HealthTechnologyAssessment #OncologyResearch #MultipleMyeloma

Exciting news! Our 2024 Environmental, Social, and Governance (ESG) report is here. This year, we’ve made meaningful progress, embedding ESG principles into our strategies to drive impactful change, foster sustainability, and deliver long-term value for all stakeholders. We’re proud of what we’ve accomplished and even more inspired to continue shaping a brighter, more sustainable future. https://hubs.ly/Q02-VrML0 #ESG #Sustainability #CorporateResponsibility #Healthcare #Biotech

Congratulations to James Baumgardner! The Journal of Managed Care & Specialty Pharmacy has recognized Jim as one of their high-performing peer reviewers for 2023. Each year, only about 15% of peer reviews are judged to be of the highest quality, and Jim's exceptional work earned him this distinction. With nearly 10 years at Precision AQ as a Scientific Advisor and Senior Research Economist, Jim continues to set a high bar for thought leadership and scientific excellence. His dedication to advancing research and providing valuable insights reflects the very best of what we stand for. Congratulations on this well-deserved honor! #ThoughtLeadership #ScientificExcellence #PharmaResearch

The final countdown to ASH 2024 is on! This year's meeting brings together the brightest minds in hematology to explore innovations that are transforming patient care and improving patient outcomes. Our team will be there, sharing insights and solutions to break down access barriers and bring life-changing medicines to patients in need. Stop by our booth or connect with us to learn more. We look forward to seeing you in San Diego!